Abstract
What is the most appropriate treatment of acute hypertensive response after intracerebral hemorrhage? Over time, two schools of thought have emerged: one that thinks blood pressure should not be treated because hematoma expansion is uncommon and perihematoma ischemia is a concern, and one that takes the opposite position. The goal of the open-label Antihypertensive Treatment of Acute Cerebral Hemorrhage trial [ATACH] was to determine the tolerability and safety of three different systolic blood pressure goals using IV nicardipine.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
